1. Sell, S. (1975). Immunology, Immunopathology, and Immunity, 2nd Ed.New York: Harper & Row, p. 384.
2.
2. Mims, C. A. (1982). The spread of microbes through the body. In: The Pathogenesis of Infectious Disease. Mims, C. A. ed. New York: Academic Press, pp. 82–108.
3.
3. Sharma, R. P. (1981). Immunity and the immune system. In: Immunologic Considerations in Toxicology. Sharma, R. P. ed. Boca Raton, FL: CRC Press, Vol. I, pp. 1–9.
4.
4. Wong, S. (1981). Immunotherapeutic agents. Encyclopedia of Chemical Technology13, 167–182.
5.
5. Hay, A. (1979). Accidents in trichlorophenol plants: A need for realistic surveys to ascertain risks to health. In: Health effects of halogenated aromatic hydrocarbons. Ann. N. Y. Acad. Sci.320, 321–324.
6.
6. Landrigan, P. J., Wilcox, K. R., Silva, J., Humphrey, H. E. B., Kauffman, C., and Heath, C. W. (1979). Cohort study of Michigan residents exposed to polybromniated biphenyls: Epidemologic and immunologic findings. In: Health effects of halogenated aromatic hydrocarbons. Ann. N. Y. Acad. Sci.320, 284–294.
7.
7. Urabe, H., Koda, H., and Asahi, M. (1979). Present state of YUSHO patients. In: Health effects of halogenated aromatic hydrocarbons. Ann. N. Y. Acad. Sci.,320, 273–276.
8.
8. Kahanawa, M., Shoya, S., Ogura, Y., Moriwaki, M., and Kawasaki, M. (1969). Nat. Inst. Animal Health Q.9, 213–219.
9.
9. Pocchiari, F., Silano, V., and Zampieri, A. (1979). Human health effects from accidental release of tetrachlorodibenzo-p-dioxin (TCDD) at Seveso, Italy. In: Health effects of halogenated aromatic hydrocarbons. Ann. N. Y. Acad. Sci.320, 311–320.
10.
10. Wassermann, M., Wassermann, D., Cucos, S., and Miller, H. J. (1979). World PCBs map: Storage and effects in man and his biological environment in the 1970s. In: Health effects of halogenated aromatic hydrocarbons. Ann. N. Y. Acad. Sci.320, 69–124.
11.
11. Bekesi, J. H., Holland, J. F., Anderson, H. A., Fischbein, A. S., Rom, W., and Selikoff, I. J. (1978). Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science199, 1207–1209.
12.
12. Bekesi, J. H., Anderson, H. A., Roboz, J. P., Roboz, J., Fischbein, A. S., Selikoff, I. J., and Holland, J. F. (1979). Immunologic dysfunction among PBB-exposed Michigan farmers. In: Health effects of halogenated aromatic hydrocarbons. Ann. N. Y. Acad. Sci.320, 717–728.
13.
13. Sharma, R. P. (1981). Immunotoxicology: General considerations. In: Immunologic Considerations in Toxicology. Sharma, R. P. ed. Boca Raton, FL: CRC Press, Vol. I, pp. 9–18.
14.
14. Califano, J. A., Jr. (1978). Establishment of a national toxicology program. Fed. Reg.43, 53060–53061.
15.
15. Moore, J. A., Huff, J. E., and Dean, J. H. (1982). The national toxicology program and immunological toxicology. Pharmacol. Rev.34, 13–16.
16.
16. Norbury, K. C. (1982). Immunotoxicology in the pharmaceutical industry. Environ. Health Perspect.43, 53–59.
17.
17. Norbury, K. C. (1982). Methods currently used in the pharmaceutical industry for evaluating immunotoxic effects. Pharmacol. Rev.34, 131–136.
18.
18. Norbury, K. C., Bloom, J. C., and Wong, S.Formation of the Immunotoxicology Discussion Group in 1983. For information, write to: K. C. Norbury, Ph.D., Department of Safety Evaluation, Ortho Pharmaceutical Corp., Route 202, Ruritun, NJ 08869.
19.
19. Dean, J. H., Luster, M. I., Boorman, G. A., and Lauer, L. D. (1982). Procedures available to examine the immunotoxicity of chemicals and drugs. Pharmacol. Rev.34, 137–148.
20.
20. Dean, J. H., Luster, M. I., and Boorman, G. A. (1982). Immunotoxicology. In: Immunopharmacology. Sirois P., and Rola-Pleszezynski, M. eds. New York: Elsevier, pp. 349–397.
21.
21. Dean, J. H., Luster, M. I., Boorman, G. A., Padarathsingh, M. L., Lusbke, R. W. and Clements, M. E. (1981). In: The Biological Relevance of Immune Suppresion Induced by Therapeutic and Environmental Agents. Dean, J. H., Padarathsingh, M. L. eds. New York: Van Norstrand and Reinhold, pp. 23–25.
22.
22. Dean, J. H., Luster, M. I., Boorman, G. A., Luebke, R. W., and Lauer, L. D. (1982). Application of tumor, bacteria, and parasite susceptibility assays to study immune alteration induced by environmental chemicals. Environ. Health Perspect.43, 81–88.
23.
23. McConnell, E. E., and Moore, J. A. (1979). Toxicology characteristics of the halogenatred aromatics. In: Health effects of halogenated aromatic hydrocarbons. Ann. N. Y. Acad. Sci.320, 138–150.
24.
24. Seinen, W., and Willems, M. I. (1976). Toxicity of organotin compounds. I. Atrophy of thymus and thymus-dependent lymphoid tissue in rats fed di-n-octyitindichloride. Toxicol. Appl. Pharmacol.35, 63–75.
25.
25. Seinen, W., and Penninks, A. (1979). Immune suppression as a consequence of selective cytotoxic activity of certain organometallic compounds on thymus and thymus-dependent lymphocytes. In: Health effects of halogenated aromatic hydrocarbons. Ann. N. Y. Acad. Sci.320, 499–517.
26.
26. Seinen, W. (1981). Immunotoxicity of alkyltin compounds. In: Immunologic Considerations in Toxicology. Sharma, R. P. ed. Boca Raton, FL: CRC Press, Vol. I, pp. 104–120.
27.
27. Vos., J. G. (1981). Screening and function tests to detect immune suppression in toxicity studies. In: Immunologic Considerations in Toxicology. Volume I. Sharma, R. P. ed. Boca Raton, FL: CRC Press, Vol. I, pp. 109–122.
28.
28. Vos., J. G., Faith, R. E., and Luster, M. I. (1980). Immune Alterations. New York: Elsevier/North Holland, pp. 241–266.
29.
29. Wong, S., and Natarajan, C. (1983). Immunotoxicology. In: A Guide to General Toxicology. Hombourger, F., Hayes, J. A., and Pelikan, E. W. eds. Basel: S. Karger, pp. 79–91.
30.
30. Sanders, V. M., and Munson, A. E. (1984). Beta-Adrenergic mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. (Submitted to J. Pharmacol. Exp. Ther.).